Vertex Pharmaceuticals
User Experience - UX Designer (Contract) 20861
Boston, MA | $0K - $0K
Qualifications
- Expertise in UX software such as Adobe XD, Figma, Sketch, Jira, and InVision
- Experience working directly with developers
- Creative problem solving and strategic thinking to create solutions that meet business goals
- Self-motivated with strong project management skills and the ability to prioritize, execute, and meet project deadlines
- Strong cross-functional collaborator with proven abilities to coordinate and work with 3rd party partners
- BA/BS degree in Design, HCI, Healthcare or related field, or equivalent practical experience
- 4+ years of relevant UX design / digital strategy experience
- Portfolio of UX design work
Responsibilities
- Vertex Guidance and Patient Support (GPS) is a world-class patient services organization that provides personalized access, education and continued adherence support for CF patients and caregivers prescribed Vertex medicines
- In this role, they’ll have the opportunity to define and shape the user experience across our digital platforms, conduct and synthesize user research, and provide direction on how to evolve our digital capabilities
- Their contributions will enhance patient, caregiver, healthcare professionals, and patient support specialist digital experiences, to support long-term patient engagement and adherence
- Manage our GPS Axis Healthcare Professional Portal maintenance lifecycle as the business product owner
- Includes: documenting bugs, providing feature enhancement recommendations, design solutioning, and user testing
- Inform, guide, and where necessary execute design deliverables that meet our business requirements and accommodate any technical limitations
- Partner with cross-functional stakeholders to guide and oversee the re-platforming of our internal resource tool
- Work directly with external agencies on website updates and redesign
- Facilitate user-experience research and synthesize results
- Cultivate strong partnerships with cross-functional teams including the communications review committee (CRC) to support business goals
Benefits
- $50-$56/hr
- The pay rate range provided is a reasonable estimate of the anticipated compensation range for this job at the time of posting
- The actual pay rate will be based on a number of factors, including skills, competencies, experience, location and/or being pursued and other job-related factors permitted by law
- 1,001-5,000 employees
- Biotechnology, Health Care, Pharmaceuticals, Healthcare Services, Healthcare, Clinical Research, Life Sciences, healthcare, Biopharmaceuticals, Medical Research
- Public Company
- Last round: Post IPO equity
- Last round: US$ 50.0M
- Boston, MA
- Company Specialties:
cystic fibrosis, alpha-1 antitrypsin deficiency (AATD), APOL1-mediated kidney diseases, sickle cell disease, beta thalassemia, Duchenne muscular dystrophy, and type 1 diabetes mellitus
Company information
Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases. We discovered and developed the first medicines to treat the underlying cause of cystic fibrosis (CF), a rare, life-threatening genetic disease. In addition to clinical development programs in CF, Vertex has more than a dozen ongoing research programs focused on the underlying mechanisms of other serious diseases. Founded in 1989 in Cambridge, Massachusetts, our corporate headquarters is now located in Boston’s Innovation District, and our international headquarters is in London, United Kingdom. We currently employ approximately 3,500 people in the United States, Europe, Canada, Australia and Latin America with nearly two-thirds of our staff dedicated to research and development. Vertex is consistently recognized as one of the industry’s top places to work by Science Magazine, The Boston Globe, Boston Business Journal and the San Diego Business Journal. Our research and medicines have also received esteemed recognitions, including the Robert J. Beall Therapeutics Development Award, the French Prix Galien and the British Pharmacological Society awards.
